CD5 Antibody / Lymphoid Malignancy Marker Antibody [clone rC5/6976] (V4165)

CD5 Antibody for IHC. Immunohistochemistry analysis of CD5 antibody staining in FFPE human tonsil tissue using a lymphoid malignancy marker antibody, clone rC5/6976. Strong membranous staining is observed in interfollicular T lymphocytes with dense labeling of T cell zones surrounding germinal centers, while follicular B cell areas remain largely negative. The staining pattern highlights normal tonsillar architecture and reflects the utility of CD5 in identifying lymphocyte populations relevant to lymphoid malignancy research and disease characterization. Heat-induced epitope retrieval was performed using pH 9 Tris-EDTA buffer for 20 minutes followed by cooling prior to antibody incubation.

CD5 Antibody for IHC. Immunohistochemistry analysis of CD5 antibody staining in FFPE human tonsil tissue using a lymphoid malignancy marker antibody, clone rC5/6976. Strong membranous staining is observed in interfollicular T lymphocytes with dense labeling of T cell zones surrounding germinal centers, while follicular B cell regions remain largely negative. The staining pattern highlights normal tonsillar architecture and reflects the relevance of CD5 in identifying lymphocyte populations associated with lymphoid malignancy and immune cell lineage analysis. Inset: PBS used in place of primary antibody shows no specific staining, confirming secondary antibody specificity. Heat-induced epitope retrieval was performed using pH 9 Tris-EDTA buffer for 20 minutes followed by cooling prior to antibody incubation.

SDS-PAGE analysis of purified, BSA-free CD5 antibody (clone rC5/6976) as confirmation of integrity and purity.